New Leaf Venture Partners, L.L.C. Affimed N.V. Transaction History

New Leaf Venture Partners, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $1.96 Million - $2.67 Million	-732,774 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.05 - $4.34 $3.26 Million - $4.63 Million	-1,067,226 Reduced 59.29%	732,774 $3.08 Million
Q3 2018 Nov 13, 2018	SELL	$1.45 - $6.15 $652,500 - $2.77 Million	-450,000 Reduced 20.0%	1,800,000 $7.83 Million
Q1 2018 May 15, 2018	BUY	$1.25 - $2.65 $2.81 Million - $5.96 Million	2,250,000 New	2,250,000 $4.16 Million

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.